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Epithelial plasticity in health and disease 
 
Speaker: M. Ángela Nieto, PhD 
Instituto de Neurociencias (CSIC-UMH), Alicante, Spain  
Date: 15/02/19- 12:00 h  
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Abstract:  
Epithelial homeostasis is crucial to maintain tissue architecture, and therefore, it needs to be 
tightly regulated in the adult. By contrast, embryonic cells show a high degree of epithelial 
plasticity required for proper morphogenesis and, in particular, for the implementation of 
massive cell movements that occur during gastrulation and neural crest delamination among 
other processes. We have been interested in the analysis of cell movements, plasticity and 
epithelial to mesenchymal transitions (EMT) for many years, and found that the reactivation of 
developmental EMT-like programs in adult cells leads to several pathologies including tumor 
progression and organ degeneration. While the epithelial and mesenchymal cells are usually 
considered as extreme phenotypes, intermediate EMT states also exist. Under those 
circumstances cells depict a hybrid phenotype expressing both epithelial and mesenchymal 
markers and from which they can reverse to the original state or move towards a more 
mesenchymal phenotype. Hybrid transitory states can favor coordinated cell migration or 
wound healing but they can also enable the formation of clusters of migratory cancer cells with 
increased metastatic potential. However, in contrast to the situation in cancer, the intermediate 
phenotype holds promise for new antifibrotic therapeutic approaches, as inhibiting EMT can 
attenuate established fibrosis.  I will discuss different scenarios in which this intermediate 
phenotype is observed both in development and in disease, and will also refer to a new 
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